おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OM1
company
About
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
- Boston,Massachusetts,United States
- 101 - 250
- http://www.om1.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20.99M
- Industries
- Big Data,Health Care,Information Technology,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Legal Name
- OM1, Inc
- Also Known As
- Better Outcomes
OM1 (formerly Better Outcomes) is a digital health company focused on solving the problem of determining and understanding the true results of healthcare. OM1 believes that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. The company leverages a state-of-the-art technology platform, a world-class team of scientists, clinical experts, software engineers, and a committed network of organizations to create a new standard for health outcomes information.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$170.99M
OM1 has raised a total of
$170.99M
in funding over 2 rounds. Their latest funding was raised on
Jul 16, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 16, 2021 | Series D | $85M | 8 |
Breyer Capital
D1 Capital Partners
Kaiser Permanente
|
— | Detail |
| Dec 18, 2019 | Series C | $50M | 4 |
Scale Venture Partners
|
— | Detail |
| May 22, 2018 | Series B | $20.99M | 3 |
Polaris Partners
|
— | Detail |
| Apr 6, 2017 | Series A | $15M | 4 |
General Catalyst
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
6
9
OM1 is funded by 9 investors.
Breyer Capital
and D1 Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Breyer Capital
|
Yes | Series D |
|
D1 Capital Partners
|
Yes | Series D |
|
Kaiser Permanente
|
Yes | Series D |
|
General Catalyst
|
— | Series D |
7wire Ventures
|
— | Series D |
|
|
— | Series D |
|
Polaris Partners
|
— | Series D |
|
Scale Venture Partners
|
— | Series D |
Wanxiang America Healthcare Investments Group
|
— | Series A |
Employee Profiles
Number of Employee Profiles
10
OM1 has 10 current employee profiles, including
Board member David Barrett
Board member
Employee
Executive
Executive
Advisor
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
